← Back to guidelines
Dermatology8 papers

Idiopathic bronchiectasis

Last edited: 4/15/2026

Overview

Idiopathic bronchiectasis is a chronic condition characterized by irreversible dilation of bronchi due to persistent inflammation and destruction of airway walls, without a clear identifiable cause [Not directly covered in provided abstracts].

Diagnosis

  • Clinical history of chronic cough, sputum production, and recurrent respiratory infections [Not directly covered in provided abstracts].
  • Chest imaging (CT scans) showing characteristic bronchial dilation and wall thickening [Not directly covered in provided abstracts].
  • Pulmonary function tests indicating airflow obstruction and air trapping [Not directly covered in provided abstracts].
  • Exclusion of other causes through appropriate diagnostic workup [Not directly covered in provided abstracts].
  • Management

  • Antibiotics for acute exacerbations and possibly long-term suppressive therapy [Not directly covered in provided abstracts].
  • Airway clearance techniques to improve mucus clearance [Not directly covered in provided abstracts].
  • Bronchodilators and inhaled corticosteroids to manage symptoms and reduce inflammation [Not directly covered in provided abstracts].
  • Nutritional support and management of complications such as malnutrition [Not directly covered in provided abstracts].
  • Exercise programs to enhance physical fitness and reduce breathlessness [Not directly covered in provided abstracts].
  • Special Populations

  • Pregnancy: Specific management guidelines are not provided in the abstracts [Not directly covered in provided abstracts].
  • Pediatrics: No specific evidence from the provided abstracts [Not directly covered in provided abstracts].
  • Elderly: Considerations for comorbidities and frailty are not addressed in the abstracts [Not directly covered in provided abstracts].
  • Comorbidities: Management of comorbidities like cystic fibrosis or immunodeficiency is not detailed in the abstracts [Not directly covered in provided abstracts].
  • Key Recommendations

  • Monitor and manage psychological symptoms, particularly depression, as elevated free testosterone levels correlate with depressive symptoms in hirsute women (Evidence: Moderate) 2.
  • Use flutamide as a pure anti-androgen in idiopathic hirsutism to effectively reduce androgen hypersensitive symptoms without significant impact on bone mineral density (Evidence: Moderate) 13.
  • Regular assessment of androgen levels and clinical status is crucial in managing idiopathic hirsutism, though direct application to bronchiectasis management is not supported by these abstracts (Evidence: Moderate) 3.
  • References

    1 Bertelloni S, Baroncelli GI, Sorrentino MC, Costa S, Battini R, Saggese G. Androgen-receptor blockade does not impair bone mineral density in adolescent females. Calcified tissue international 1997. link 2 Derogatis LR, Rose LI, Shulman LH, Lazarus LA. Serum androgens and psychopathology in hirsute women. Journal of psychosomatic obstetrics and gynaecology 1993. link 3 Couzinet B, Pholsena M, Young J, Schaison G. The impact of a pure anti-androgen (flutamide) on LH, FSH, androgens and clinical status in idiopathic hirsutism. Clinical endocrinology 1993. link

    Original source

    1. [1]
      Androgen-receptor blockade does not impair bone mineral density in adolescent females.Bertelloni S, Baroncelli GI, Sorrentino MC, Costa S, Battini R, Saggese G Calcified tissue international (1997)
    2. [2]
      Serum androgens and psychopathology in hirsute women.Derogatis LR, Rose LI, Shulman LH, Lazarus LA Journal of psychosomatic obstetrics and gynaecology (1993)
    3. [3]
      The impact of a pure anti-androgen (flutamide) on LH, FSH, androgens and clinical status in idiopathic hirsutism.Couzinet B, Pholsena M, Young J, Schaison G Clinical endocrinology (1993)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG